Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study

Geoffrey Bellini, Samit K Datta, Nicholas Sich, Maharaj Singh, James Weese, Federico A Sanchez, Nalini Guda, Wesley Papenfuss, Aaron H Chevinsky, Aurora Gastroenterology Fellows, Aurora Complex General Surgical Oncology Fellows, Aurora Gastroenterology Faculty

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Oncology
DOIs
StatusPublished - Feb 1 2020

Keywords

  • pancreatic cancer
  • neoadjuvant therapy (NAT)
  • pancreatic adenocarcinoma (PA)

Cite this